CAS RN: 175396-30-2
Ethyl 7-oxo-4,5,6,7-tetrahydro-1h-indazole-3-carboxylate
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 175396-30-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
175396-30-2 / ethyl 7-oxo-2,4,5,6-tetrahydroindazole-3-carboxylate
Standard CAS: 175396-30-2
Multi CAS: No
Basic Information
copy
CAS
175396-30-2 copy
Multi CAS
No copy
Molecular Formula
C10H12N2O3 copy
Molecular Weight
208.210000 copy
Exact Mass
208.084792 copy
SMILES
CCOC(=O)C1=C2CCCC(=O)C2=NN1 copy
InChI
InChI=1S/C10H12N2O3/c1-2-15-10(14)9-6-4-3-5-7(13)8(6)11-12-9/h2-5H2,1H3,(H,11,12) copy
InChIKey
XFLFPYFSAQLHCN-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
5 copy
Fraction Csp3
0.5 copy
Rotatable bonds
2 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
51.81 copy
TPSA
72.05 copy
LogP / Solubility
WLOGP
1.11 copy
MLOGP
0.97 copy
XLogP3
1.2 copy
Consensus LogP
1.09 copy
Log S (ESOL)
-1.94 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-2.07 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.17 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.21 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy